Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Liu

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of the American Chemical Society|January 18, 2019
A Click Chemistry Approach Reveals the Chromatin-Dependent Histone H3K36 Deacylase Nature of SIRT7Wesley Wei Wang, Maria Angulo-Ibanez, Jie Lyu, et al.
ACS Medicinal Chemistry Letters|June 19, 2024
SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the EnzymeLauren R Blankenship, Kai S Yang, Veerabhadra R Vulupala, et al.
Molecular Cancer Therapeutics|March 28, 2014
Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathwaysKhristofer Garcia, Jonathan L Blank, David C Bouck, et al.
Journal of Medicinal Chemistry|April 12, 2024
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main ProteaseYugendar R Alugubelli, Jing Xiao, Kaustav Khatua, et al.
Molecular Cancer Therapeutics|May 22, 2012
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphomaJudy Quiju Shi, Kerri Lasky, Vaishali Shinde, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
The P3 <i>O</i> - <i>Tert</i> -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease InhibitorsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
The <i>N</i> -Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease InhibitorsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
Science Advances|April 8, 2026
From vibrations to function: Spectroscopic detection and quantification of π-π stacking in drug-responsive protein complexesNarangerel Altangerel, Esther J Ocola, Benjamin W Neuman, et al.
ACS Central Science|March 1, 2022
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, et al.
European Journal of Medicinal Chemistry|July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antiviralsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of the American Chemical Society|January 18, 2019
A Click Chemistry Approach Reveals the Chromatin-Dependent Histone H3K36 Deacylase Nature of SIRT7Wesley Wei Wang, Maria Angulo-Ibanez, Jie Lyu, et al.
ACS Medicinal Chemistry Letters|June 19, 2024
SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the EnzymeLauren R Blankenship, Kai S Yang, Veerabhadra R Vulupala, et al.
Molecular Cancer Therapeutics|March 28, 2014
Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathwaysKhristofer Garcia, Jonathan L Blank, David C Bouck, et al.
Journal of Medicinal Chemistry|April 12, 2024
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main ProteaseYugendar R Alugubelli, Jing Xiao, Kaustav Khatua, et al.
Molecular Cancer Therapeutics|May 22, 2012
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphomaJudy Quiju Shi, Kerri Lasky, Vaishali Shinde, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
The P3 <i>O</i> - <i>Tert</i> -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease InhibitorsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
The <i>N</i> -Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease InhibitorsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
Science Advances|April 8, 2026
From vibrations to function: Spectroscopic detection and quantification of π-π stacking in drug-responsive protein complexesNarangerel Altangerel, Esther J Ocola, Benjamin W Neuman, et al.
ACS Central Science|March 1, 2022
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, et al.
European Journal of Medicinal Chemistry|July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antiviralsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
Pageof 10